HUTCHINSON, Kan. — A dispute over rural health care access and pharmaceutical policy escalated Thursday after Kansas House Speaker Dan Hawkins adjourned the House, effectively blocking debate on Senate Bill 284.
Supporters of the measure, including officials with PrairieStar Health Center, say the move prevents consideration of legislation aimed at restoring discounted drug shipments to rural pharmacies under the federal 340B program.
Senate Bill 284 would require pharmaceutical manufacturers to resume shipping 340B-priced medications to certain rural pharmacies that partner with critical access hospitals and community health centers. Advocates argue the bill is necessary to stabilize rural health systems that rely on those discounts to offset operating costs and maintain services.
Opponents, including pharmaceutical manufacturers, have resisted such mandates in multiple states, citing concerns over program oversight and distribution practices.
The 340B program, established by Congress in 1992, requires drug manufacturers participating in Medicare and Medicaid to provide discounted medications to eligible safety-net providers. In recent years, however, several drugmakers have limited shipments to contract pharmacies, including those in rural areas, prompting legal and legislative battles nationwide.
Bryant Anderson, CEO of PrairieStar Health Center, criticized the decision to adjourn the House, arguing it delays protections for rural providers.
“These actions leave rural Kansans uncertain about the future of their hospitals, health centers and pharmacies,” Anderson said in a press release.
According to supporters of SB 284, rural providers depend on revenue generated through the 340B program to sustain operations. They warn that continued restrictions on drug shipments could threaten access to care in underserved communities, particularly as some facilities already operate on thin or negative margins.
Industry data indicates pharmaceutical revenues continue to grow, with global sales projected to approach $2 trillion by 2027, while many rural providers face ongoing financial strain.
Similar legislation has been enacted in more than 20 states, reflecting a broader national effort to address disputes over the 340B program and preserve rural health infrastructure.